Weinschenk T - Search Results

1

Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.

Löffler MW, Gori S, Izzo F, Mayer-Mokler A, Ascierto PA, Königsrainer A, Ma YT, Sangro B, Francque S, Vonghia L, Inno A, Avallone A, Ludwig J, Alcoba DD, Flohr C, Aslan K, Mendrzyk R, Schuster H, Borrelli M, Valmori D, Chaumette T, Heidenreich R, Gouttefangeas C, Forlani G, Tagliamonte M, Fusco C, Penta R, Iñarrairaegui M, Gnad-Vogt U, Reinhardt C, Weinschenk T, Accolla RS, Singh-Jasuja H, Rammensee HG, Buonaguro L. Löffler MW, et al. Among authors: weinschenk t. Clin Cancer Res. 2022 Jun 13;28(12):2555-2566. doi: 10.1158/1078-0432.CCR-21-4424. Clin Cancer Res. 2022. PMID: 35421231 Clinical Trial.

2

Integrated functional genomics approach for the design of patient-individual antitumor vaccines.

Weinschenk T, Gouttefangeas C, Schirle M, Obermayr F, Walter S, Schoor O, Kurek R, Loeser W, Bichler KH, Wernet D, Stevanović S, Rammensee HG. Weinschenk T, et al. Cancer Res. 2002 Oct 15;62(20):5818-27. Cancer Res. 2002. PMID: 12384544

3

Towards patient-specific tumor antigen selection for vaccination.

Rammensee HG, Weinschenk T, Gouttefangeas C, Stevanović S. Rammensee HG, et al. Among authors: weinschenk t. Immunol Rev. 2002 Oct;188:164-76. doi: 10.1034/j.1600-065x.2002.18815.x. Immunol Rev. 2002. PMID: 12445290 Review.

4

Moderate degradation does not preclude microarray analysis of small amounts of RNA.

Schoor O, Weinschenk T, Hennenlotter J, Corvin S, Stenzl A, Rammensee HG, Stevanović S. Schoor O, et al. Among authors: weinschenk t. Biotechniques. 2003 Dec;35(6):1192-6, 1198-201. doi: 10.2144/03356rr01. Biotechniques. 2003. PMID: 14682053 Free article.

5

Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.

Schmidt SM, Schag K, Müller MR, Weinschenk T, Appel S, Schoor O, Weck MM, Grünebach F, Kanz L, Stevanovic S, Rammensee HG, Brossart P. Schmidt SM, et al. Among authors: weinschenk t. Cancer Res. 2004 Feb 1;64(3):1164-70. doi: 10.1158/0008-5472.can-03-2538. Cancer Res. 2004. PMID: 14871853

6

Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes.

Schag K, Schmidt SM, Müller MR, Weinschenk T, Appel S, Weck MM, Grünebach F, Stevanovic S, Rammensee HG, Brossart P. Schag K, et al. Among authors: weinschenk t. Clin Cancer Res. 2004 Jun 1;10(11):3658-66. doi: 10.1158/1078-0432.CCR-03-0640. Clin Cancer Res. 2004. PMID: 15173072

7

A conserved sequence in the mouse variable T cell receptor alpha recombination signal sequence 23-bp spacer can affect recombination.

Probst J, Blumenthal SG, Tenzer S, Weinschenk T, Dittmer J, Schoor O, Six A, Rammensee HG, Pascolo S. Probst J, et al. Among authors: weinschenk t. Eur J Immunol. 2004 Aug;34(8):2179-90. doi: 10.1002/eji.200424910. Eur J Immunol. 2004. PMID: 15259015 Free article.

8

Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectrometry.

Dengjel J, Decker P, Schoor O, Altenberend F, Weinschenk T, Rammensee HG, Stevanovic S. Dengjel J, et al. Among authors: weinschenk t. Eur J Immunol. 2004 Dec;34(12):3644-51. doi: 10.1002/eji.200425510. Eur J Immunol. 2004. PMID: 15495271 Free article.

9

CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors.

Dittmann J, Keller-Matschke K, Weinschenk T, Kratt T, Heck T, Becker HD, Stevanović S, Rammensee HG, Gouttefangeas C. Dittmann J, et al. Among authors: weinschenk t. Cancer Immunol Immunother. 2005 Aug;54(8):750-8. doi: 10.1007/s00262-004-0640-7. Epub 2004 Dec 22. Cancer Immunol Immunother. 2005. PMID: 15614528 Free PMC article.

10

Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy.

Krüger T, Schoor O, Lemmel C, Kraemer B, Reichle C, Dengjel J, Weinschenk T, Müller M, Hennenlotter J, Stenzl A, Rammensee HG, Stevanović S. Krüger T, et al. Among authors: weinschenk t. Cancer Immunol Immunother. 2005 Sep;54(9):826-36. doi: 10.1007/s00262-004-0650-5. Epub 2004 Dec 31. Cancer Immunol Immunother. 2005. PMID: 15627209 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters